summary
Introduced
11/15/2022
11/15/2022
In Committee
11/16/2022
11/16/2022
Crossed Over
Passed
Dead
01/03/2023
01/03/2023
Introduced Session
117th Congress
Bill Summary
A BILL To amend the Federal Food, Drug, and Cosmetic Act to facilitate the exchange of certain product information, and for other purposes.
AI Summary
This bill, the Pre-Approval Information Exchange Act of 2022, amends the Federal Food, Drug, and Cosmetic Act to facilitate the exchange of certain product information between drug and device manufacturers and payors, formulary committees, or other similar entities. It allows for the sharing of information about investigational drugs or devices that have not yet been approved, cleared, or licensed by the FDA, as long as certain requirements are met, such as including clear disclaimers and avoiding claims about safety or efficacy. The bill also requires the Government Accountability Office to conduct a study on the provision and use of this information after 5 years and 6 months of enactment.
Committee Categories
Business and Industry, Health and Social Services
Sponsors (6)
Brett Guthrie (R)*,
Michael Burgess (R),
Anna Eshoo (D),
Morgan Griffith (R),
Doris Matsui (D),
Scott Peters (D),
Last Action
Referred to the Subcommittee on Health. (on 11/16/2022)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/117th-congress/house-bill/9297/all-info |
| BillText | https://www.congress.gov/117/bills/hr9297/BILLS-117hr9297ih.pdf |
| Bill | https://www.congress.gov/117/bills/hr9297/BILLS-117hr9297ih.pdf.pdf |
Loading...